+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Microcarrier Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • PDF Icon

    Report

  • 143 Pages
  • November 2023
  • Region: Global
  • IMARC Group
  • ID: 5911953
The global microcarrier market size reached US$ 1.6 Billion in 2022. Looking forward, the market is expected to reach US$ 2.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.45% during 2022-2028.

Microcarriers are beads manufactured using different materials like gelatin, dextran, cellulose, plastic, and glass. They provide anchorage or an attachment surface for the suspended cell culture, which aids in increasing the viability of cells. They also enhance the production capacity, improve culture robustness, facilitate process scale-up, and reduce cell manufacturing costs. As a result, they are widely utilized in cell-line production and with bioreactors. Moreover, as they are easy to handle and have a high surface-to-volume ratio, they are gaining traction worldwide as an alternative to monolayer procedures for nerve and muscle cultures.

Microcarrier Market Trends

Microcarriers are extensively used during the production of vaccines to increase protein-producing and virus-generating adherent cell populations. This, along with the urgent need for mass vaccination to control the spread of the coronavirus disease (COVID-19), represents one of the key factors impelling the market growth. In addition, the rising prevalence of viral diseases is catalyzing the demand for microcarrier-based vaccine delivery systems. These systems modulate the immune responses and other immunostimulatory compounds, thereby increasing the availability of antigens to the immune cells. Apart from this, dissolvable microcarriers composed of cross-linked polysaccharide polymers are widely being used in large-scale cell production and in cell therapy applications. This, in confluence with the rising geriatric population and the risk of developing cancer with age, is catalyzing the demand for cell therapeutics and microcarriers. Furthermore, researchers are focusing on introducing microcarriers using a genetic algorithm and a transient liquid molding optofluidic approach. They are also developing three-dimensional (3D) shaped hydrogel cell microcarriers that allow adherent culture and self-alignment for imaging flow cytometry. This is projected to contribute to the market growth.

Key Market Segmentation

This research provides an analysis of the key trends in each sub-segment of the global microcarrier market report, along with forecasts at the global, regional and country level from 2023-2028. The report has categorized the market based on product, material type, application and end user.

Breakup by Product:

  • Equipment
  • Bioreactors
  • Culture Vessels
  • Filtration Systems
  • Cell Counters
  • Accessories
  • Consumables
  • Media
  • Reagents
  • Microcarrier Beads

Breakup by Material Type:

  • Alginate-based
  • Collagen-based
  • Dextran-based
  • Polystyrene-based

Breakup by Application:

  • Vaccine Manufacturing
  • Cell Therapy

Breakup by End User:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organizations (CROs)

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Latin America
  • Brazil
  • Mexico
  • Middle East and Africa

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players being CESCO Bioengineering Co. Ltd., ChemoMetec A/S, Corning Incorporated, Cytiva (Danaher Corporation), Eppendorf AG, Esco VacciXcell, HiMedia Laboratories, Lonza Group AG, Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc. and VWR International LLC (Avantor Inc.).

Key Questions Answered in This Report:

  • How has the global microcarrier market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global microcarrier market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the material type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global microcarrier market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Microcarrier Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Equipment
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Bioreactors
6.1.2.2 Culture Vessels
6.1.2.3 Filtration Systems
6.1.2.4 Cell Counters
6.1.2.5 Accessories
6.1.3 Market Forecast
6.2 Consumables
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Media
6.2.2.2 Reagents
6.2.2.3 Microcarrier Beads
6.2.3 Market Forecast
7 Market Breakup by Material Type
7.1 Alginate-based
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Collagen-based
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Dextran-based
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Polystyrene-based
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Application
8.1 Vaccine Manufacturing
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Cell Therapy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by End User
9.1 Pharmaceutical and Biotechnology Companies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Academic and Research Institutes
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Contract Research Organizations (CROs)
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 CESCO Bioengineering Co. Ltd.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 ChemoMetec A/S
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.3 Corning Incorporated
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Cytiva (Danaher Corporation)
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Eppendorf AG
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 SWOT Analysis
15.3.6 Esco VacciXcell
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 HiMedia Laboratories
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Lonza Group AG
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Merck KGaA
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Sartorius AG
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Thermo Fisher Scientific Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 VWR International LLC (Avantor Inc.)
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio

Companies Mentioned

  • CESCO Bioengineering Co. Ltd.
  • ChemoMetec A/S
  • Corning Incorporated
  • Cytiva (Danaher Corporation)
  • Eppendorf AG
  • Esco VacciXcell
  • HiMedia Laboratories
  • Lonza Group AG
  • Merck KGaA
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • VWR International LLC (Avantor Inc.)

Methodology

Loading
LOADING...

Table Information